Subscribe for email alerts
Donate to Science & Enterprise
|
By Alan, on November 19th, 2015% Ingestible electronic device that measures heart and respiratory rates (Albert Swiston, MIT Lincoln Laboratory)
19 November 2015. Engineering and medical researchers developed and tested in pigs a swallowed capsule with sensors that records heart and respiratory rates in real time. The team from the bioengineering lab of Robert Langer and Lincoln Laboratory at . . . → Read More: Vital-Signs Sensors Built Into Ingestible Capsule
By Alan, on November 18th, 2015% (NEC Corporation of America with Creative Commons license)
18 November 2015. A collaboration of genomic profiling and software companies plans to integrate their services to provide what they call more informed precision medicine treatment options for cancer patients. Financial aspects of the agreement between genetic diagnostics enterprise Caris Life Sciences in Irving, Texas . . . → Read More: Genomic, Patient Data Integrated for Precision Medicine
By Alan, on November 18th, 2015% (aboutmodafinil.com, Flickr)
18 November 2015. Two repositories of brain tissue for research on neurological disorders agreed to coordinate their donation and distribution policies for studies of autism. The agreement aims to bring into alignment policies and practices of NeuroBioBank at National Institutes of Health and Autism BrainNet, a private tissue bank.
The deal . . . → Read More: Brain Tissue Banks Partner on Autism Research
By Alan, on November 17th, 2015% Triangular gold nanoparticles in microRNA sensor (Indiana University-Purdue University Indianapolis)
17 November 2015. Biochemical and medical researchers developed a technique for sensitive detection of RNA in humans that in lab tests can distinguish between benign conditions and cancer. The team from the lab of chemistry professor Rajesh Sardar at Indiana University-Purdue University Indianapolis . . . → Read More: Nanotech Sensors Devised for RNA Cancer Detection
By Alan, on November 17th, 2015% (Public Domain Pictures, Pixabay)
17 November 2015. A new biotechnology company developing therapies that use tiny cellular containers to deliver their payloads is spun off from M.D. Anderson Cancer Center and raising $80 million in early venture funding. Codiak Biosciences, based in Cambridge, Massachusetts is founded and licensing research by Raghu Kalluri, chair . . . → Read More: Exosome Therapy Start-Up Launches, Raises $80M
By Alan, on November 16th, 2015% Dogs with Voyce health monitors (i4C Innovations)
16 November 2015. The veterinary medicines company Zoetis is sponsoring a study of pain management and quality of life in dogs with osteoarthritis, using a mobile health monitor worn by the dogs. The 900 dogs serving as subjects in the study will wear the health monitor . . . → Read More: Study Explores Quality of Life for Dogs with Arthritis
By Alan, on November 16th, 2015% Tor Ny (Umeå University)
16 November 2015. Umeå University and the pharmaceutical company Prometic are partnering on development of new treatments for chronic wounds, such as diabetic foot ulcers and bed sores. The agreement gives Prometic, in Laval, Quebec, Canada an exclusive license to the university’s research on the blood plasma protein plasminogen, . . . → Read More: Licensing, Research Deal Aims at Chronic Wound Treatments
By Alan, on November 13th, 2015% RNA molecule illustration (Nicolle Rager Fuller, National Science Foundation)
13 November 2015. In a new challenge on InnoCentive, a pharmaceutical company specializing in skin disorders is seeking a new minimally-invasive procedure for skin biopsies to provide samples for RNA analysis. The competition, sponsored by Leo Pharma in Ballerup, Denmark has a purse of . . . → Read More: Less-Invasive Skin Biopsy Sought in $30K Challenge
By Alan, on November 13th, 2015% (Public Domain Pictures/Pixabay)
13 November 2015. University of Pennsylvania’s medical school plans to apply liquid biopsy technology developed by Epic Sciences to gain a more detailed understanding of different cancers for individual patient therapies. Financial terms of the agreement between the university and the San Diego biotechnology company were not disclosed.
Epic Sciences’s . . . → Read More: Penn, Epic Sciences Partner on Liquid Biopsies
By Alan, on November 12th, 2015% (DARPA.gov)
12 November 2015. A global collaboration plans a series of clinical trials that address precise molecular targets testing treatments for glioblastoma multiforme, an aggressive brain cancer. The alliance combines medical teams, researchers, and patient advocates to employ adaptive clinical trials, a type of clinical study that enables investigators to adjust research tactics . . . → Read More: Alliance Plans Adaptive Clinical Trials for Brain Cancer
|
Welcome to Science & Enterprise Science and Enterprise is an online news service begun in 2010, created for researchers and business people interested in taking scientific knowledge to the marketplace.
On the site’s posts published six days a week, you find research discoveries destined to become new products and services, as well as news about finance, intellectual property, regulations, and employment.
|
You must be logged in to post a comment.